Red blood cell–tumour cell interactions promote tumour cell progression
Analytical validation of ANGLE’s combined IF and FISH assay for assessment of HER2 in circulating tumor cells
Complementary insights: Exploring the dual analysis of circulating tumour cells and circulating DNA
A melanoma brain metastasis CTC signature and CTC:B cell clusters associate with secondary liver metastasis: a melanoma brain-liver metastasis axis
Digoxin for reduction of circulating tumour cell cluster size in metastatic breast cancer
Identification and characterization of tumor and stromal derived liquid biopsy analytes in pancreatic ductal adenocarcinoma
SABCS: A novel, semi-automated Pipeline for HER2 Quantification on CTCs in breast cancer patients. Is cytopathology of peripheral blood a new diagnostic option?
CIRCUS: CIRCUlating tumour cells in soft tissue Sarcoma – a short report
Comprehensive liquid biopsy analysis for monitoring NSCLC patients under second-line osimertinib treatment
Multi-marker analysis of circulating tumor cells in localized intermediate/high-risk and metastatic prostate cancer